We Put the Whole Dry Needling Decision on One Page — and Nine Experts Agreed on All of It

Why we did this

Dry needling has been part of physical therapy practice for over two decades, and the research base has grown every year. But if you put ten well-trained clinicians in a room, you will get ten slightly different answers on how many needles, how aggressive, when to needle the spine instead of the sore spot, and what to do once the needle comes out. The technique is everywhere. The decision-making behind it has never really been standardized. That gap is what we set out to close.

How it was built (and what it is — and isn't)

We used a modified Delphi process, which is the standard way to build expert consensus. Nine physical therapists, chosen for real depth in dry needling and orthopedic practice, worked through four structured rounds of questions, review, and revision until we agreed. And we did agree — unanimously, on all of it.

I will be straight about what that means, because precision cuts both ways. This is a Level V paper. That is expert consensus, not a big randomized trial, and we say so plainly in the paper. It does not replace the need for better long-term research on dosing and outcomes. What it does is take the collective judgment of people who do this every day and organize it into one shared framework, so we are all speaking the same language and reasoning through the same steps.

What's actually in the decision tree

The heart of the paper is a decision tree that walks the whole treatment from the first screen to the last rep. Here is the short version.

1. Screen before you needle

Candidacy comes first. Someone with musculoskeletal pain, mobility loss, weakness, or movement dysfunction may be a good fit — but only after you clear absolute contraindications, work through precautions, and can honestly say the benefit outweighs the risk for this specific person. And a handful of high-risk regions stay off the table unless you have specific training: the thorax, the pelvic floor, neurovascular bundles, the jaw, and the front of the neck.

2. Dose by irritability, not by habit

This is one of the most practical pieces. The dose — how many needles, how aggressive, how much stimulation — should follow the patient's irritability and how much treatment they can tolerate, not your routine. A highly irritable, low-tolerance patient gets a minimal dose: one to two passes, or stop at the first twitch. A calm, high-tolerance patient can handle a comprehensive session across multiple regions. Same diagnosis, three very different doses.

3. Know when to needle the spine

When the neurological exam lights up — deficits in dermatomes, myotomes, deep tendon reflexes, or neurodynamic mobility — the driver may be central. In that case you direct needling at the spinal segment first, treat the involved level, and reassess before you ever chase the painful periphery. When it's a local problem, a regional assessment (strength, range, palpation, special tests) guides where you work.

4. Verify, then load

The needle does not end the treatment. Right after needling you reassess to confirm something actually changed, then you load the treated tissue — local loading first, then functional loading like squats, carries, and lifts — and you educate the patient on what to expect. Hydrate, keep moving, expect some soreness for a day or two, reach out if anything is off. That post-needling piece is the bridge between a short-term change and a lasting one.

The bigger point

If there is one idea this whole paper is built on, it is this: the outcome is not driven by the needle in isolation. It is driven by how you decide to use it — the screen, the dose, the reassessment, and the loading that follows. The needle is a delivery tool. The decision is the treatment.

That is the framework we teach, and now it is written down, peer-reviewed, and free for anyone to read. If you needle — or you train people who do — the decision tree is worth a few minutes and a hallway conversation.